Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2024 Filed Mar 15, 2024 01:30 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 64,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004848 · doc4.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,307,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:22 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004847 · doc4.xml · derivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:22 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 16,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004847 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,368,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:15 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004846 · doc4.xml · derivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:15 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionCommon Stock | 16,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004846 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 22:10 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 29,378 | $2.40 | $70,457.26 |
DisclosureSEC source: 0001209191-24-004790 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478,061 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.34 to $2.46 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:23 UTC |
Moore CarolSVP Reg. & Quality
|
GrantRestricted Stock Unit | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004447 · doc4.xml · nonDerivative · entry 1 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 499,576 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 2,338 and 6,323 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/23 and 02/29/24, respectively. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:22 UTC |
Jensen ChrystalChief Legal Officer
|
GrantRestricted Stock Unit | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004445 · doc4.xml · nonDerivative · entry 1 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 509,530 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:20 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantRestricted Stock Unit | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004444 · doc4.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 906,694 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 2,007 and 6,617 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/23 and 02/29/24, respectively. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:18 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantRestricted Stock Unit | 575,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004443 · doc4.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,242,541 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 2,578 and 6,617 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/23 and 02/29/24, respectively. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:17 UTC |
Green Kevin DennisChief Financial Officer
|
GrantRestricted Stock Unit | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004442 · doc4.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 639,639 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 3,676 shares purchased under Issuer's Employee Stock Purchase Plan on 02/29/24, respectively. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:16 UTC |
CORASH LAURENCE MChief Scientific Officer
|
GrantRestricted Stock Unit | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004441 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,351,501 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:14 UTC |
Benjamin Richard JChief Medical Officer
|
GrantRestricted Stock Unit | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004440 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 507,439 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| December 13, 2023 Filed Dec 13, 2023 22:55 UTC |
BJERKHOLT ERICDirector
|
PurchaseCommon Stock | 10,000 | $1.62 | $16,200.00 |
DisclosureSEC source: 0001209191-23-058544 · doc4.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,133 Read SEC document |
| August 22, 2023 Filed Aug 23, 2023 22:11 UTC |
Lucena AnnDirector
|
PurchaseCommon Stock | 7,500 | $1.69 | $12,637.50 |
DisclosureSEC source: 0001209191-23-047111 · doc4.xml · nonDerivative · entry 1 Lucena Ann · CIK 0001876751 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,284 Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 22:08 UTC |
BJERKHOLT ERICDirector
|
PurchaseCommon Stock | 10,000 | $1.72 | $17,151.00 |
DisclosureSEC source: 0001209191-23-047110 · doc4.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,133 Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:17 UTC |
Witney FrankDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-23-035806 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,059 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:16 UTC |
Swisher Daniel N JRDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-23-035796 · doc4.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,545 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Since the date of the reporting person's last ownership report, the number of shares beneficially owned by the reporting person has been reduced by 54,263 shares pursuant to the terms of a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:13 UTC |
SCHULZE GAILDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-23-035770 · doc4.xml · nonDerivative · entry 1 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,420 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:11 UTC |
NACHTSHEIM JAMI KDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-23-035766 · doc4.xml · nonDerivative · entry 1 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,362 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:10 UTC |
MOORE TIMOTHY L.Director
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-23-035763 · doc4.xml · nonDerivative · entry 1 MOORE TIMOTHY L. · CIK 0001669207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,073 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:08 UTC |
Lucena AnnDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-23-035757 · doc4.xml · nonDerivative · entry 1 Lucena Ann · CIK 0001876751 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,784 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:07 UTC |
BJERKHOLT ERICDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-23-035749 · doc4.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,133 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| May 26, 2023 Filed May 30, 2023 19:45 UTC |
Swisher Daniel N JRDirector
|
PurchaseCommon Stock | 5,000 | $1.91 | $9,535.00 |
DisclosureSEC source: 0001209191-23-032850 · doc4.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,808 F1 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.905 to $1.910 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth. Read SEC document |
| May 24, 2023 Filed May 24, 2023 23:18 UTC |
SCHULZE GAILDirector
|
PurchaseCommon Stock | 9,850 | $2.03 | $19,980.73 |
DisclosureSEC source: 0001209191-23-032014 · doc4.xml · nonDerivative · entry 1 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,420 F1 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.025 to $2.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth. Read SEC document |
| May 23, 2023 Filed May 23, 2023 21:57 UTC |
BJERKHOLT ERICDirector
|
PurchaseCommon Stock | 5,000 | $2.00 | $10,000.00 |
DisclosureSEC source: 0001209191-23-031710 · doc4.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,133 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 00:00 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 3,350 | $2.80 | $9,380.00 |
DisclosureSEC source: 0001209191-23-018688 · doc4.xml · nonDerivative · entry 4 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,915 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 00:00 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 9,728 | $2.80 | $27,238.40 |
DisclosureSEC source: 0001209191-23-018688 · doc4.xml · nonDerivative · entry 2 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,598 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:56 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 8,791 | $2.80 | $24,614.80 |
DisclosureSEC source: 0001209191-23-018685 · doc4.xml · nonDerivative · entry 4 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,070 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:56 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 16,565 | $2.80 | $46,382.00 |
DisclosureSEC source: 0001209191-23-018685 · doc4.xml · nonDerivative · entry 2 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641,861 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:50 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 5,758 | $2.80 | $16,122.40 |
DisclosureSEC source: 0001209191-23-018684 · doc4.xml · nonDerivative · entry 4 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,530 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:50 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 9,710 | $2.80 | $27,188.00 |
DisclosureSEC source: 0001209191-23-018684 · doc4.xml · nonDerivative · entry 2 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,621 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:47 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 22,732 | $2.80 | $63,649.60 |
DisclosureSEC source: 0001209191-23-018683 · doc4.xml · nonDerivative · entry 4 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,658,346 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:47 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 37,748 | $2.80 | $105,694.40 |
DisclosureSEC source: 0001209191-23-018683 · doc4.xml · nonDerivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,616,411 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:43 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 7,501 | $2.80 | $21,002.80 |
DisclosureSEC source: 0001209191-23-018681 · doc4.xml · nonDerivative · entry 4 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,963 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:43 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 9,662 | $2.80 | $27,053.60 |
DisclosureSEC source: 0001209191-23-018681 · doc4.xml · nonDerivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,797 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:38 UTC |
CORASH LAURENCE MChief Scientific Officer
|
SaleCommon Stock | 5,745 | $2.80 | $16,086.00 |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,261,501 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:38 UTC |
CORASH LAURENCE MChief Scientific Officer
|
SaleCommon Stock | 9,597 | $2.80 | $26,871.60 |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250,579 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:34 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 10,000 | $2.78 | $27,793.00 |
DisclosureSEC source: 0001209191-23-018677 · doc4.xml · nonDerivative · entry 5 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,439 F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.895 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:34 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 5,747 | $2.80 | $16,091.60 |
DisclosureSEC source: 0001209191-23-018677 · doc4.xml · nonDerivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,439 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:34 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 9,606 | $2.80 | $26,896.80 |
DisclosureSEC source: 0001209191-23-018677 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,519 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2023 Filed Mar 15, 2023 00:00 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018688 · doc4.xml · derivative · entry 6 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,666 Underlying: Common Stock · 11,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2023 Filed Mar 15, 2023 00:00 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018688 · doc4.xml · derivative · entry 5 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,460 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2023 Filed Mar 15, 2023 00:00 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionCommon Stock | 11,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018688 · doc4.xml · nonDerivative · entry 3 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,265 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 15, 2023 00:00 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionCommon Stock | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018688 · doc4.xml · nonDerivative · entry 1 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:56 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018685 · doc4.xml · derivative · entry 6 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:56 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 44,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018685 · doc4.xml · derivative · entry 5 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:56 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018685 · doc4.xml · nonDerivative · entry 3 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:56 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionCommon Stock | 44,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018685 · doc4.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:50 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018684 · doc4.xml · derivative · entry 6 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,666 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.